Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T19722 |
Benazeprilat
CGS14831,CGS-14831,CGS 14831 |
RAAS; Endogenous Metabolite | Endocrinology/Hormones; Metabolism |
Benazeprilat(CGS 14831) 是一种具有口服活性的贝那普利活性代谢物。Benazeprilat 具有高效的抗血压活性,可与其他其他类别的化合物(包括噻嗪类利尿剂和钙通道阻滞剂)联合使用来减少与心血管风险和继发性终末器官损伤相关的疾病的发生。Benazeprilat 可能用于研究急性左心室衰竭。 | |||
T71005 |
CGP-42456A
|
||
CGP-42456A - Benazepril Related Compound A, it is an Impurity. Benazepril is a prodrug which is metabolized by the liver into its active form benazeprilat via cleavage of the drug's ester group. Benazepril and Benazeprilat inhibit angiotensin-converting enzyme (ACE) in human subjects and animals. Benazeprilat has much greater ACE inhibitory activity than does Benazepril. It is indicated for the treatment of hypertension. |